Cure My Disease

Don't miss your cure!

 Log in / Sign up

Experimental cancer drug THOR-707 tested in patients with advanced tumors

NCT ID NCT04009681

Terminated Disease control Sponsor: Synthorx, Inc, a Sanofi company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called THOR-707 in adults with advanced solid tumors that had spread. The goal was to find safe doses and see if the drug could shrink tumors when used alone or with other treatments. The study was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm metastatic neoplasm neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTASIS

Contacts and locations

Locations

  • Investigational Site Number- 6001

    Santiago, Chile

  • Investigational Site Number-1001

    San Antonio, Texas, 78229, United States

  • Investigational Site Number-1002

    Houston, Texas, 77030, United States

  • Investigational Site Number-1003

    Nashville, Tennessee, 37203, United States

  • Investigational Site Number-1004

    Sarasota, Florida, 34232, United States

  • Investigational Site Number-1005

    Denver, Colorado, 80218, United States

  • Investigational Site Number-1007

    Dallas, Texas, 75032, United States

  • Investigational Site Number-1008

    Scottsdale, Arizona, 85250, United States

  • Investigational Site Number-2001

    Perth, Australia

  • Investigational Site Number-2002

    Victoria, Australia

  • Investigational Site Number-2003

    Victoria, Australia

  • Investigational Site Number-2004

    New South Whales, Australia

  • Investigational Site Number-4002

    Singapore, Singapore

  • Investigational Site Number-5001

    Barcelona, Spain

  • Investigational Site Number-5002

    Madrid, Spain

  • Investigational Site Number-5003

    Madrid, Spain

  • Investigational Site Number-5004

    Madrid, Spain

  • Investigational Site Number-5005

    Madrid, Spain

  • Investigational Site Number-5006

    Barcelona, Spain

  • Investigational Site Number-5007

    Barcelona, Spain

  • Investigational Site Number-5105

    Madrid, Spain

  • Investigational Site Number-6002

    Santiago, Chile

  • Investigational Site Number-7002

    Buenos Aires, Argentina

  • Investigational Site-4001

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.